Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$6K Sell
69
-1,125
-94% -$94.2K 0.29% 116
2016
Q4
$104K Buy
1,194
+350
+41% +$29.7K 0.49% 72
2016
Q3
$67K Sell
844
-32
-4% -$2.47K 0.33% 112
2016
Q2
$66K Sell
876
-24
-3% -$1.9K 0.32% 112
2016
Q1
$77K Sell
900
-140
-13% -$12K 0.33% 101
2015
Q4
$110K Sell
1,040
-194
-16% -$20.9K 0.47% 77
2015
Q3
$120K Buy
1,234
+320
+35% +$31.1K 0.53% 60
2015
Q2
$77K Sell
914
-512
-36% -$44.4K 0.32% 119
2015
Q1
$130K Sell
1,426
-216
-13% -$18.1K 0.52% 71
2014
Q4
$122K Buy
1,642
+208
+15% +$14.7K 0.48% 82
2014
Q3
$87K Buy
+1,434
New +$88.4K 0.36% 112
2014
Q2
Sell
-54
Closed -$3K 233
2014
Q1
$3K Buy
+54
New +$2.81K 0.01% 192
2013
Q3
Sell
-1,879
Closed -$98K 232
2013
Q2
$98K Buy
+1,879
New +$105K 0.45% 88

Other funds holding ANDV

New York Life Trust's ANDV Position: Q1 2017 in Review

New York Life Trust reduced its Andeavor (ANDV) stake by 94% in Q1 2017, selling an estimated $94.2K and leaving 69 shares worth $6K. The position accounts for 0.29% of the portfolio, ranked #116.

New York Life Trust first reported a position in ANDV in Q2 2013 and has held it in 13 quarters since. The position peaked at $130K in Q1 2015. 498 funds tracked by Wall St. Rank hold ANDV as of Q1 2017.

  • New York Life Trust held 69 shares of Andeavor worth $6K as of Q1 2017.
  • New York Life Trust sold 1,125 Andeavor shares in Q1 2017, an estimated $94.2K.
  • Andeavor made up 0.29% of New York Life Trust's portfolio in Q1 2017, its #116 holding.
  • New York Life Trust first reported a position in Andeavor in Q2 2013 and has held it in 13 quarters since.
  • New York Life Trust's Andeavor position peaked at $130K in Q1 2015.
  • 498 funds tracked by Wall St. Rank held Andeavor as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.